Kent Imaging Responds to a Complaint Filed with the ITC Concerning SnapshotGLO® and Reaffirms Commitment to Clinical Innovation
Kent Imaging today issued a statement regarding the complaint filed by MolecuLight Corp. and MolecuLight Inc. in the U.S. International Trade Commission (ITC). The complaint alleges that Kent Imaging’s SnapshotGLO®, which recently received FDA 510(k) clearance, infringes a patent to which MolecuLight purports to have a license. Kent Imaging denies all allegations of patent infringement […]